Enhanced fear responses in mice treated with anabolic androgenic steroids

NeuroReport

Volumn 20, Issue 6, 2009, Pages 617-621

  Agis Balboa, Roberto Carlos ^a   Pibiri, Fabio ^a   Nelson, Marianela ^a   Pinna, Graziano ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Anabolic androgenic steroids; Contextual fear conditioning; Gamma aminobutyric acid A receptors; Neurosteroids; Selective brain steroidogenic stimulants

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 3ALPHA HYDROXYSTEROID DEHYDROGENASE; ANDROGEN; MESSENGER RNA; NORFLUOXETINE; STEROID 5ALPHA REDUCTASE; TESTOSTERONE PROPIONATE; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ANABOLIC AGENT; DRUG DERIVATIVE; ELTANOLONE; FLUOXETINE; GLUTAMIC ACID; STEROID;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; ASSOCIATION; BRAIN CELL; CONDITIONING; CONTROLLED STUDY; DOWN REGULATION; FEAR; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; THALAMUS; ANIMAL; DRUG EFFECT; GENE EXPRESSION; METABOLISM; NERVE CELL; PHYSIOLOGY;

3-HYDROXYSTEROID DEHYDROGENASES; AMYGDALA; ANABOLIC AGENTS; ANDROGENS; ANIMALS; CONDITIONING (PSYCHOLOGY); FEAR; FEMALE; FLUOXETINE; GENE EXPRESSION; GLUTAMIC ACID; HIPPOCAMPUS; MICE; NEURONS; PREFRONTAL CORTEX; PREGNANOLONE; RNA, MESSENGER; STEROIDS; TESTOSTERONE 5-ALPHA-REDUCTASE; TESTOSTERONE PROPIONATE;

EID: 67049097594     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e32832a2393     Document Type: Article

References (25)

1. Gruber AJ, Pope HG Jr. Psychiatric and medical effects of anabolic- androgenic steroid use in women. Psychother Psychosom 2000; 69:19-26.
2. Pearson HA. Dangerous elixir? Nature 2004; 431:500-501.
3. Irvin LM, Wall M, Neumark-Sztainer D, Story MN. Steroid using among adolescents: finding from project EAT. JAdolesc Health 2002; 30:243-252.
4. Sjöqvist F, Garle M, Rane A. Use of doping agents, particularly anabolic steroids, in sports and society. Lancet 2008; 371:1872-1882.
5. Grimes JM, Melloni RH Jr. Prolonged alterations in the serotonin neural system following the cessation of adolescent anabolic-androgenic steroid exposure in hamsters (Mesocricetus auratus). Behav Neurosci 2006; 120:1242-1251.
6. Ricci LA, Grimes JM, Melloni RH Jr. Lasting changes in neuronal activation patterns in select forebrain regions of aggressive, adolescent anabolic/ androgenic steroid-treated hamsters. Behav Brain Res 2007; 176:344-352.
7. Pinna G, Costa E, Guidotti A. Changes in brain testosterone and allopregnanolone biosynthesis elicit aggressive behavior. Proc NatlAcad Sci USA 2005; 102:2135-2140.
8. McGinnis MY, Lumia AR, Breuer ME, Possidente B. Physical provocation potentiates aggression in male rats receiving anabolic androgenic steroids. Horm Behav 2002; 41:101-110.
9. Pibiri F, Nelson M, Carboni G, Pinna G. Neurosteroids regulate mouse aggression induced by anabolic androgenic steroids. Neuroreport 2006;17:1537-1541.
10. Clark AS, Costine BA, Jones BL, Kelton-Rehkopf MC, Meerts SH, Nutbrown-Greene LL, et al. Sex- and age-specific effects of anabolic androgenic steroids on reproductive behaviors and on GABAergic transmission in neuroendocrine control regions. Brain Res 2006;1126:122-138.
11. A receptor subunit mRNAs in the mouse forebrain. Neuropharmacology2002;43:634-645.
12. Morris JA, Jordan CL, Breedlove SM. Sexual differentiation on the vertebrate nervous system. Nat Neurosci 2004; 7:1034-1039.
13. Areceptor. Nat Rev Neurosci 2005; 6:565-575.
14. A receptors. Neuron 1990;4:759-765.
15. Agis-Balboa RC, Pinna G, Zhubi A, Maloku E, Veldic M, Costa E, Guidotti A. Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. Proc Natl Acad Sci USA 2006;103:14602-14607.
16. Agis-Balboa RC, Pinna G, Pibiri F, Kadriu B, Costa E, Guidotti A. Downregulation of 5α-reductase type I mRNA expression in cortico-limbic glutamatergic neurons in socially-isolated mice. Proc Natl Acad Sci USA 2007; 104:18736-18741.
17. Pibiri F, Nelson M, Guidotti A, Costa E, Pinna G. Decreased allopregnanolone content during social isolation enhances contextual fear: a model relevant for posttraumatic stress disorder. Proc Natl Acad Sci USA 2008; 105:5567-5572.
18. Pinna G, Galici R, Schneider HH, Stephens DN, Turski L. Alprazolam dependence prevented by substituting with the beta-carboline abecarnil. Proc Natl Acad Sci USA 1997; 94:2719-2723.
19. Dong E, Matsumoto K, Uzunova V, Sugaya I, Costa E, Guidotti A. Brain 5α-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation. Proc Natl Acad Sci USA 2001; 98:2849-2854.
20. Phillips RG, LeDoux JE. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 1992; 106:274-285.
21. Herry C, Ciocchi S, Senn V, Demmou L, Muller C, Luthi A. Switching on and off fear by distinct neuronal circuits. Nature 2008; 454:600-605.
22. Milad MR, Quirk GJ, Pitman RK, Orr SP, Fischl B, Rauch SL. A role for the human dorsal anterior cingulate cortex in fear expression. Biol Psychiatry 2007; 62:1191-1194.
23. Rauch SL, Shin LM, Phelps EA. Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research - past, present, and future. Biol Psychiatry2006; 60:376-382.
24. A receptors through two discrete transmembrane sites. Nature 2006; 444:486-489.
25. Pinna G, Costa E, Guidotti A. SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake. Curr Opin Pharmacol 2009; 9:24-30.